Pfizer will have to pay rebates to Medicare for five drugs under Biden plan to lower Rx costs

CNBC News

16 March 2023 - Five of Pfizer’s drugs will cost less for Medicare recipients starting next month as part of President Joe Biden’s plan to lower prescription drug costs, the Department of Health and Human Services said.

Pfizer’s drugs include the blood thinner Fragmin, which was approved by the FDA in 1994. It also includes Atgam, a medicine used to treat symptoms of renal allograft and aplastic anaemia, and the chemotherapy injection Nipent. Pfizer’s antibacterial drugs Bicillin L-A, used for treating syphilis, and Bicillin C-R are also included. Both drugs are also used to treat upper respiratory infections.

Read CNBC News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicare